Literature DB >> 22018957

Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: implications for brain energy metabolism and neurotrophic signaling.

W T Regenold1, M Pratt, S Nekkalapu, P S Shapiro, T Kristian, G Fiskum.   

Abstract

The pathophysiology of mood and psychotic disorders, including unipolar depression (UPD), bipolar disorder (BPD) and schizophrenia (SCHZ), is largely unknown. Numerous studies, from molecular to neuroimaging, indicate that some individuals with these disorders have impaired brain energy metabolism evidenced by abnormal glucose metabolism and mitochondrial dysfunction. However, underlying mechanisms are unclear. A critical feature of brain energy metabolism is attachment to the outer mitochondrial membrane (OMM) of hexokinase 1 (HK1), an initial and rate-limiting enzyme of glycolysis. HK1 attachment to the OMM greatly enhances HK1 enzyme activity and couples cytosolic glycolysis to mitochondrial oxidative phosphorylation, through which the cell produces most of its adenosine triphosphate (ATP). HK1 mitochondrial attachment is also important to the survival of neurons and other cells through prevention of apoptosis and oxidative damage. Here we show, for the first time, a decrease in HK1 attachment to the OMM in postmortem parietal cortex brain tissue of individuals with UPD, BPD and SCHZ compared to tissue from controls without psychiatric illness. Furthermore, we show that HK1 mitochondrial detachment is associated with increased activity of the polyol pathway, an alternative, anaerobic pathway of glucose metabolism. These findings were observed in samples from both medicated and medication-free individuals. We propose that HK1 mitochondrial detachment could be linked to these disorders through impaired energy metabolism, increased vulnerability to oxidative stress, and impaired brain growth and development.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018957     DOI: 10.1016/j.jpsychires.2011.09.018

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  36 in total

Review 1.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

2.  Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia.

Authors:  Dan Shan; Daniel Mount; Stephen Moore; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2014-02-21       Impact factor: 4.939

3.  Energization by multiple substrates and calcium challenge reveal dysfunctions in brain mitochondria in a model related to acute psychosis.

Authors:  Jamila Monteiro; Gabriela Assis-de-Lemos; Eduardo de-Souza-Ferreira; Adriana M Marques; Gilda A Neves; Mariana S Silveira; Antonio Galina
Journal:  J Bioenerg Biomembr       Date:  2019-12-18       Impact factor: 2.945

4.  Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.

Authors:  Danya Ben-Hail; Racheli Begas-Shvartz; Moran Shalev; Anna Shteinfer-Kuzmine; Arie Gruzman; Simona Reina; Vito De Pinto; Varda Shoshan-Barmatz
Journal:  J Biol Chem       Date:  2016-10-13       Impact factor: 5.157

Review 5.  Astroglial glutamate transporters coordinate excitatory signaling and brain energetics.

Authors:  Michael B Robinson; Joshua G Jackson
Journal:  Neurochem Int       Date:  2016-03-21       Impact factor: 3.921

6.  Effects of Mood Stabilizers on Brain Energy Metabolism in Mice Submitted to an Animal Model of Mania Induced by Paradoxical Sleep Deprivation.

Authors:  Emilio L Streck; Giselli Scaini; Gabriela C Jeremias; Gislaine T Rezin; Cinara L Gonçalves; Gabriela K Ferreira; Gislaine Z Réus; Wilson R Resende; Samira S Valvassori; Flávio Kapczinski; Mônica L Andersen; João Quevedo
Journal:  Neurochem Res       Date:  2015-04-17       Impact factor: 3.996

7.  De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment.

Authors:  Volkan Okur; Megan T Cho; Richard van Wijk; Brigitte van Oirschot; Jonathan Picker; Stephanie A Coury; Dorothy Grange; Linda Manwaring; Ian Krantz; Colleen Clark Muraresku; Peter J Hulick; Holley May; Eric Pierce; Emily Place; Kinga Bujakowska; Aida Telegrafi; Ganka Douglas; Kristin G Monaghan; Amber Begtrup; Ashley Wilson; Kyle Retterer; Kwame Anyane-Yeboa; Wendy K Chung
Journal:  Eur J Hum Genet       Date:  2019-02-18       Impact factor: 4.246

Review 8.  An emerging role for mitochondrial dynamics in schizophrenia.

Authors:  Kyle H Flippo; Stefan Strack
Journal:  Schizophr Res       Date:  2017-05-16       Impact factor: 4.939

9.  Altered metabolic activity in the developing brain of rats predisposed to high versus low depression-like behavior.

Authors:  Chelsea R McCoy; Samantha R Golf; Miguel Melendez-Ferro; Emma Perez-Costas; Matthew E Glover; Nateka L Jackson; Sara A Stringfellow; Phyllis C Pugh; Andrew D Fant; Sarah M Clinton
Journal:  Neuroscience       Date:  2016-03-12       Impact factor: 3.590

10.  Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder.

Authors:  J Ernst; A Hock; A Henning; E Seifritz; H Boeker; S Grimm
Journal:  Mol Psychiatry       Date:  2016-05-17       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.